Azenta completes $63M B Medical Systems sale

• Azenta (NASDAQ:AZTA) completed the sale of its B Medical Systems business to Thelema S.à r.l. for a fixed cash purchase price of $63 million.
• The transaction supports Azenta’s strategy to simplify its portfolio and focus on core life sciences businesses.
• A portion of the purchase price was financed through a $35 million short-term secured vendor loan provided by an Azenta subsidiary.

Azenta (NASDAQ:AZTA) completed the sale of its B Medical Systems business to Thelema S.à r.l. on July 1, 2026.

The transaction, initially announced on December 29, 2025, was completed at a fixed cash purchase price of $63 million.

Azenta disclosed that $35 million of the purchase price was funded through a short-term secured vendor loan issued by an Azenta subsidiary to Thelema.

Following the transaction, Azenta said the divestiture aligns with its strategy to simplify its business portfolio, concentrate resources on its core life sciences operations, and improve financial flexibility.

B Medical Systems specializes in temperature-controlled storage and transport solutions, including systems used in healthcare and life sciences applications.

The sale allows Azenta to streamline operations while continuing to focus on areas such as biological sample management, life sciences research solutions, and related technologies.